alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Bureau of Prisons

          - 28 CFR Part 540
          - [BOP–1149]
          - RIN 1120–AB49

# AGENCY:

Bureau of Prisons, Justice Department.

# ACTION:

Interim final rule; technical correction.

      ( print page 25111)    

# SUMMARY:

                        This document corrects the                         **dates**                         section of an interim final rule published on Friday, April 23, 2010. In the interim rule, the Bureau of Prisons (Bureau) revised its regulations regarding inmate contact with the community to remove two current Bureau regulations that prohibit inmates from publishing under a byline, due to a recent court ruling invalidating Bureau regulation language containing this prohibition. The April 23, 2010, publication inadvertently omitted an effective date.                    

# DATES:

The interim final rule published April 23, 2010, at 75 FR 21163, is effective May 7, 2010. Comments are due by June 22nd, 2010.

# ADDRESSES:

Rules Unit, Office of General Counsel, Bureau of Prisons, 320 First Street, NW., Washington, DC 20534.

# FOR FURTHER INFORMATION CONTACT:

Sarah Qureshi, Office of General Counsel, Bureau of Prisons, phone (202) 307–2105.

# SUPPLEMENTARY INFORMATION:

                    This document corrects the                     **DATES**                     section of the publication on Friday, April 23, 2010 (75 FR 21163). The                     **dates**                     section of that document should read as follows: “This rule is effective on [insert date of publication]. Comments are due by June 22nd, 2010.” However, because that document did not include an effective date, this document announces the effective date of those provisions.                

# List of Subjects in 28 CFR Part 540

Prisoners.

Harley G. Lappin,

Director, Bureau of Prisons.

[FR Doc. 2010–10727 Filed 5–6–10; 8:45 am]

BILLING CODE P
### MANDATE



## Court of Appeals

**First District of Texas**

NO. 01

- 14

- 00798

- CV

IN THE INTEREST OF A .A.M. AND J.M. , children

Appeal from the 314th District Court of Harris County. (Tr. Ct. No. 2011

- 00219J ).

TO THE 314TH DISTRICT COURT OF HARRIS COUNTY, GREETINGS:

Before this Court , on the 17th day of March 2015 , the case upon appeal to revise or

to reverse your judgment was determined. This Court made its order in these words:

This case is an appeal from the final judgment signed by the trial court on September 8, 2014. After submitting the case on the appellate record and the arguments properly raised by the parties, the Court holds that the trial co urt’s judgment contains no reversible error. Accordingly, the Court affirms the trial court’s judgment.

The Court orders that the appellant, Avery Juwon Myrick, pay all appellate costs.

The Court orders that this decision be certified belowfor observ ance.

Judgment rendered March 17, 2015.

Panel consists of Justices Keyes, Bland, and Massengale. Opinion delivered by Justice Bland.

WHEREFORE, WE COMMAND YOU to observe the order of our said Court in

this behalf and in all things to have it duly recogn ized, obeyed, and executed.

June 26, 2015

Date CHRISTOPHER A. PRINE

CLERK OF THE COURT
|   | (1) | The Report fully      complies with the requirements of Section 13(a) or 15(d) of the Securities      Exchange Act of 1934; and                                   |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |
|   | (2) | The information      contained in the Report fairly presents, in all material respects, the      financial condition and results of operations of the    Company. |
|   |
|   |

|                     Date: November      14, 2008 | /s/   Owen      Farren                                                      |
|----------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                             | Owen      Farren                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                             | Director,      President and Chief Executive Officer                                                                                                                                                                                                                                                                                                           |
|                                                                                                                             |
|                                                                                                                             |
|                                                                                                                             |
|                                                                                                                             |
EXHIBIT 10.96  [* * *].  Certain
information in this exhibit has been omitted and filed separately with the
Commission.  Confidential treatment has
been requested with respect to the omitted portions.  AMENDMENT #1
TO
REVENUE SHARING PURCHASE AGREEMENT (AGREEMENT #001)  This Amendment No. 1 to Revenue Sharing Purchase Agreement (the Amendment) is entered into effective as of
December 17, 2003 by and between UTStarcom, Inc., a Delaware corporation
(UTStarcom), and MultiData, a Honduras Republic corporation (Purchaser).  WHEREAS, UTStarcom and Purchaser entered into a Revenue Sharing Purchase
Agreement dated as of October 21, 2003 (the Agreement
or from now on also named Agreement #001); and  WHEREAS, the parties wish to amend Agreement #001, as set forth
herein;  NOW THEREFORE, in consideration of the foregoing and upon the mutual
agreement of the parties, Agreement #001 is hereby amended as follows:  1.In Exhibit A, page 5 of
Agreement #001, Paragraph (c) of Section 12.3 shall be revised to
read as follows:  (c)Purchaser assigns in any manner (by operation of law or otherwise) its
rights and responsibilities under this Agreement, without the prior written
consent of UTStarcom.  Notwithstanding
the foregoing, UTStarcom hereby consents to the assignment by Purchaser, within
ninety (90) days from the date hereof, of Purchasers rights and
obligations under this Agreement to [***], a commercial entity
that has been created by Purchaser in order to operate Purchasers business
with the Products ([***]shall hereinafter be referred to as Purchasers Affiliate).  Purchasers Affiliate shall be partially
owned by Purchaser.  Despite the
assignment of rights and obligations under this Agreement to Purchasers Affiliate,
until otherwise agreed Purchaser shall remain liable for the full performance
of all obligations hereunder in the event that Purchasers Affiliate fails to
perform.  2.In Exhibit B, page 9 of
Agreement #001, an additional bullet point under the heading Services
for Phase I shall be added and shall read as follows:  [***]  3.In Exhibit B, page 10 of
Agreement #001, an additional bullet point under the heading Services
for Phase II shall be added and shall read as follows:  [***]  4.In Exhibit B, page 11 of
Agreement #001, an additional bullet point under the heading Services
for Phase III shall be added and shall read as follows:  [***]  1 
   5.In Exhibit B, page 11 of
Agreement #001, an additional bullet point under the heading Services
for Phase IV shall be added and shall read as follows:  [***]  6.Section 5.3 of Exhibit E shall be
deleted in its entirety.  7.All other provisions of Agreement #001
shall remain in full force and effect.  IN WITNESS WHEREOF, this Amendment has been executed as of the dates
first above written.  UTSTARCOM, INC.
  PURCHASERBy:
  /s/ Rene Mendez
  
  By:
  /s/ Jose Rafael FerrariPrinted Name:
  Rene Mendez
  
  Printed Name:
  Jose Rafael FerrariTitle:
  VP of Sales, CA LA
  
  Title:
  President  2
EX-10.14



 Exhibit 10.14 

Amendment No. 3 to Collaboration and License Agreement 

This Amendment No. 3 to Collaboration and License Agreement (this “Amendment No. 3”) is made and
effective as of December 1, 2015, by and between Proteostasis Therapeutics, Inc., a corporation existing under the laws of the State of Delaware, having a place of business at 200 Technology Square, 4th Floor, Cambridge, MA 02139
(“PTI”) and Astellas Pharma Inc., a Japanese corporation having its principal place of business at 5-1 Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, Japan (“Astellas”). Each of
Astellas and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties”. 

Reference is hereby made to that certain Collaboration and License Agreement dated November 4, 2014 and amended on May 1, 2015 and August 5,
2015, by and between the Parties (the “Agreement”). Capitalized terms used, but not defined herein shall have the meanings ascribed to such terms in the Agreement. 

WHEREAS, the Parties now wish to further amend the Agreement pursuant to the terms and conditions set forth herein; 

NOW, THEREFORE, in consideration of the premises, the mutual covenants contained herein and other valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 
 1. Section 2.3(b) is deleted in its entirety and
replaced with the following language: 
 “(b) Hit Series. Following the HTS Phase for each Project, PTI will present the results
of the HTS Phase to the JRC and the JRC will assess the results of the HTS Phase in accordance with the guideline set forth in the Research Plan (Hit Series Criteria Guideline) and the potential development path for various screened Active
Compounds. Following the presentation of the results of the HTS Phase to the JRC, Astellas may designate one or more Hit Series to be taken forward into the Optimization Phase by providing written notice to PTI no later than January 31, 2016.
Following the conclusion of the HTS Phase, if an Active Compound is not included in a Hit Series designated by Astellas to be taken forward into the Optimization Phase, it will thereafter be a Discontinued Compound and may not thereafter be
designated as part of a Hit Series.” 
 2. Except as amended hereby, all other terms of the Agreement shall remain unchanged and in
full force and effect. 
 3. This Amendment No. 3 will be governed by, and construed in accordance with, the laws of the state of New York,
without taking into consideration any choice of law principles that would lead to the application of the laws of another jurisdiction. 

Signatures Appear on the Page Immediately Following 







 IN WITNESS WHEREOF, the Parties have caused this Amendment No. 3 to be executed by their duly authorized
representatives. 
  

							
	ASTELLAS PHARMA INC. 	    	PROTEOSTASIS THERAPEUTICS, INC.
				
	By:	 	 /s/Shunichiro Matsumoto
	    	By:	 	 /s/Meenu Chhabra

				
	Name: 	 	Shunichiro Matsumoto	    	Name: 	 	Meenu Chhabra
				
	Title:	 	Vice President, Innovation Management	    	Title: 	 	President and Chief Executive Officer


  
 2
CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

     

In connection with the Quarterly Report of **Great Walll Builders Ltd.,**(the "Company")on Form10-Q/A for the period ended **December 31, 2010**as filed with the Securities and Exchange Commission on the date hereof(the "report"), I, **Tian Jia,** Chief Executive Officer/ Chief Financial Officer/ Principal Accounting Officer of theCompany, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Actof 1934; and

 

(2) The information contained in this Report fairly presents, in all material respects, the financial conditionand results of operations of the Company.

 

 

Dated this date: July 11, 2011

 

/s/ Tian Jia

 Tian Jia

 

Chief Executive Officer & Chief Financial Officer
White Mountain Titanium Corp.: Exhibit 10.1 - Filed by newsfilecorp.com






AMENDMENT NO. 1

TO THE 
MANAGEMENT
SERVICES AGREEMENT 

THIS AMENDMENT (the “Amendment”), effective the
1st day of January 2016, (the “Effective Date”) is to the
Management Services Agreement dated 1 July 2014 (the “Agreement”), by and
between White Mountain Titanium Corporation (“WMTC”) and Rich Top
Management Limited, a Hong Kong corporation (the “Service Provider”).


RECITALS: 

A.     WMTC finds it necessary to preserve
its cash assets until additional funding can be secured for future
operations;

B.     The Service Provider is willing to
decrease the amount of monthly compensation to assist the Company in preserving
its cash on hand; and 

C.     Section 8(d) of the Agreement grants
to the parties the right to amend the Agreement upon approval of each of the
parties thereto. 

NOW, THEREFORE, the parties hereto agree as follows: 

1.     On and as of the Effective Date the
monthly fee payable by the Company to the Service Provider under Section 2(a) of
the Agreement is reduced from US$13,500 to US$10,500. 

2.     Except as amended hereby, the
Agreement shall continue to be, and shall remain, in full force and effect.
Except as provided herein, this Amendment shall not be deemed (i) to be a waiver
of, or consent to, or a modification or amendment of, any other term or
condition of the Agreement or (ii) to prejudice any right or rights which the
parties may now have or may have in the future under or in connection with the
Agreement or any of the instruments or agreements referred to therein, as the
same may be amended, restated, supplemented or otherwise modified from time to
time. 

3.     The terms of the Agreement are
incorporated herein by reference and shall form a part of this Amendment as if
set forth herein in their entirety. 

[SIGNATURE PAGE FOLLOWS] 




IN WITNESS WHEREOF, each of the parties hereto has executed
this Amendment No. 1 the respective day and year set forth below. 

	  	White Mountain Titanium
      Corporation 
	 	 
	 	 
	Date: December 18, 2015 	By 	/s/
      Michael P. Kurtanjek 
	  		Michael P. Kurtanjek, President 
	 	 	 
	 	 	 
	  	Rich Top Management Limited
  
	 	 
	 	 
	Date: December 18, 2015 	By 	/s/
      Kin Wong 
	  		Kin Wong, Chief Executive Officer



2
Exhibit
32.2





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report of
Bluefly, Inc. (the “Company”) on Form 10-K for the year ending December 31,
2008, as filed with the Securities and Exchange Commission on the date hereof
(the “Report”), I, Kara B. Jenny, Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:





1.  The Report fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and





2.  The information contained
in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.





/s/ Kara B.
      JennyKara
      B. JennyChief Financial OfficerMarch
      5, 2009
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER ON MOTION

Cause number: 01-16-01006-CV

Style: In the Interest of J.H.G., a Child

Date motion filed*: December 23, 2016

Type of motion: Motion to Extend Time to File Notice of Appeal

Party filing motion: Appellant

Document to be filed: Notice of appeal

Is appeal accelerated? No

If motion to extend time:

Original due date: December 21, 2016

Number of previous extensions granted: Current Due date:

Date Requested: December 22, 2016

Ordered that motion is:

 Granted

If document is to be filed, document due: December 22, 2016

 Absent extraordinary circumstances, the Court will not grant additional motions to extend time

 Denied

 Dismissed (e.g., want of jurisdiction, moot)

 Other: _____________________________________ 

Judge's signature: /s/ Russell Lloyd

X Acting individually  Acting for the Court

Panel consists of ____________________________________________

Date: January 10, 2017
Exhibit
32.1





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906 OF


THE
SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2009 of Auburn Bancorp, Inc. (the “Company”) as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Allen
T. Sterling, President and Chief Executive Officer of the Company, hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:


(1)
              
              The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and(2)
              
              The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.




The
foregoing certification shall not be deemed to be filed for purposes of Section
18 of the Securities Exchange Act of 1934 or otherwise subject to liability
under that section. This certification shall not be deemed to be incorporated by
reference into any filing under the Securities Act of 1933 or the Exchange Act
except to the extent this Exhibit 32.1 is expressly and specifically
incorporated by reference in any such filing.


Date:
      May 14, 2009
                    /s/
      Allen T. SterlingName:  Allen
      T. SterlingTitle:    President
      and Chief Executive
Officer




A signed
original of this written statement required by 18 U.S.C. Section 1350 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon
request.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<RESTATED> 
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JAN-03-1998
<PERIOD-START>                             DEC-29-1996
<PERIOD-END>                               SEP-27-1997
<CASH>                                          10,594
<SECURITIES>                                    13,844
<RECEIVABLES>                                   27,211
<ALLOWANCES>                                       800
<INVENTORY>                                     28,059
<CURRENT-ASSETS>                                82,439
<PP&E>                                          94,093
<DEPRECIATION>                                  34,467
<TOTAL-ASSETS>                                 149,568
<CURRENT-LIABILITIES>                           20,581
<BONDS>                                          7,600
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           784
<OTHER-SE>                                     112,213
<TOTAL-LIABILITY-AND-EQUITY>                   149,568
<SALES>                                        125,269
<TOTAL-REVENUES>                               125,269
<CGS>                                           96,627
<TOTAL-COSTS>                                  107,102
<OTHER-EXPENSES>                               (1,188)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  29
<INCOME-PRETAX>                                 19,326
<INCOME-TAX>                                     7,826
<INCOME-CONTINUING>                             11,500
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,500
<EPS-PRIMARY>                                      .75
<EPS-DILUTED>                                      .72
        

</TABLE>
Exhibit 31.6

NANOGEN, INC.

CERTIFICATIONS REQUIRED BY RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Robert Saltmarsh, certify that:



|1. | I have reviewed this annual report on Form 10-K/A of Nanogen, Inc.; and
|-- | -----------------------------------------------------------------------



|2. | Based on my knowledge, this report on Form 10-K/A does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

June 26, 2006



/s/ ROBERT SALTMARSHRobert Saltmarsh Chief Financial Officer
(Principal Financial and Accounting Officer)